Beese Fulmer Investment Management, Inc. Abbott Laboratories Transaction History

Beese Fulmer Investment Management, Inc.

$1.14 Billion
Q3 2024

A detailed history of Beese Fulmer Investment Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Beese Fulmer Investment Management, Inc. holds 95,394 shares of ABT stock, worth $11.2 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

95,394

Previous 95,892 0.52%

Holding current value

$11.2 Million

Previous $9.96 Million 9.14%

% of portfolio

0.95%

Previous 0.92%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$100.07 - $118.13 $49,834 - $58,828	-498 Reduced 0.52%	95,394 $10.9 Million
Q2 2024 Jul 03, 2024	BUY	$100.73 - $112.44 $69,705 - $77,808	692 Added 0.73%	95,892 $9.96 Million
Q1 2024 Apr 08, 2024	BUY	$109.52 - $120.96 $88,273 - $97,493	806 Added 0.85%	95,200 $10.8 Million
Q4 2023 Jan 09, 2024	BUY	$90.19 - $110.4 $37,338 - $45,705	414 Added 0.44%	94,394 $10.4 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $56,649 - $67,969	-593 Reduced 0.63%	93,980 $9.1 Million
Q2 2023 Jul 11, 2023	SELL	$100.78 - $112.29 $105,919 - $118,016	-1,051 Reduced 1.1%	94,573 $10.3 Million
Q1 2023 Apr 11, 2023	BUY	$96.86 - $114.01 $5,811 - $6,840	60 Added 0.06%	95,624 $9.68 Million
Q4 2022 Jan 17, 2023	BUY	$95.06 - $111.52 $127,950 - $150,105	1,346 Added 1.43%	95,564 $0
Q3 2022 Oct 06, 2022	BUY	$96.76 - $112.03 $222,064 - $257,108	2,295 Added 2.5%	94,218 $9.12 Million
Q2 2022 Jul 11, 2022	BUY	$102.07 - $123.37 $30,620 - $37,011	300 Added 0.33%	91,923 $9.99 Million
Q1 2022 Apr 12, 2022	SELL	$114.02 - $139.04 $121,431 - $148,077	-1,065 Reduced 1.15%	91,623 $10.8 Million
Q4 2021 Jan 10, 2022	SELL	$115.53 - $141.46 $172,832 - $211,624	-1,496 Reduced 1.59%	92,688 $13 Million
Q3 2021 Oct 08, 2021	SELL	$116.66 - $129.06 $276,484 - $305,872	-2,370 Reduced 2.45%	94,184 $11.1 Million
Q2 2021 Jul 08, 2021	SELL	$105.79 - $124.53 $306,473 - $360,763	-2,897 Reduced 2.91%	96,554 $11.2 Million
Q1 2021 Apr 23, 2021	SELL	$108.84 - $128.23 $386,273 - $455,088	-3,549 Reduced 3.45%	99,451 $11.9 Million
Q4 2020 Jan 20, 2021	SELL	$105.0 - $114.42 $320,985 - $349,781	-3,057 Reduced 2.88%	103,000 $11.3 Million
Q3 2020 Oct 08, 2020	SELL	$91.64 - $111.29 $234,964 - $285,347	-2,564 Reduced 2.36%	106,057 $11.5 Million
Q2 2020 Jul 17, 2020	SELL	$76.57 - $98.0 $439,358 - $562,324	-5,738 Reduced 5.02%	108,621 $9.93 Million
Q1 2020 Apr 09, 2020	SELL	$62.82 - $91.86 $89,330 - $130,624	-1,422 Reduced 1.23%	114,359 $9.02 Million
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $118,785 - $132,236	1,513 Added 1.32%	115,781 $10.1 Million
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $1.4 Million - $1.52 Million	17,164 Added 17.68%	114,268 $9.56 Million
Q2 2019 Jul 05, 2019	SELL	$72.88 - $85.0 $86,654 - $101,065	-1,189 Reduced 1.21%	97,104 $8.17 Million
Q1 2019 Apr 05, 2019	BUY	$66.22 - $80.06 $41,718 - $50,437	630 Added 0.65%	98,293 $7.86 Million
Q4 2018 Jan 25, 2019	BUY	$65.56 - $74.27 $77,688 - $88,009	1,185 Added 1.23%	97,663 $7.06 Million
Q3 2018 Oct 09, 2018	BUY	$60.81 - $73.36 $119,978 - $144,739	1,973 Added 2.09%	96,478 $7.08 Million
Q2 2018 Jul 20, 2018	BUY	$57.57 - $63.54 $238,973 - $263,754	4,151 Added 4.59%	94,505 $5.76 Million
Q1 2018 Apr 16, 2018	BUY	$56.27 - $63.62 $79,509 - $89,895	1,413 Added 1.59%	90,354 $5.41 Million
Q4 2017 Jan 26, 2018	SELL	$53.68 - $57.47 $27,752 - $29,711	-517 Reduced 0.58%	88,941 $5.08 Million
Q3 2017 Oct 17, 2017	BUY	$48.06 - $53.64 $4.3 Million - $4.8 Million	89,458	89,458 $4.77 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beese Fulmer Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beese Fulmer Investment Management, Inc. with notifications on news.

Account

Beese Fulmer Investment Management, Inc. Abbott Laboratories Transaction History